{"id":"https://openalex.org/W2048657397","doi":"https://doi.org/10.1097/ftd.0b013e3181867a6e","title":"Trough Concentrations of Lopinavir, Nelfinavir, and Nevirapine With Standard Dosing in Human Immunodeficiency Virus-Infected Pregnant Women Receiving 3-Drug Combination Regimens","display_name":"Trough Concentrations of Lopinavir, Nelfinavir, and Nevirapine With Standard Dosing in Human Immunodeficiency Virus-Infected Pregnant Women Receiving 3-Drug Combination Regimens","publication_year":2008,"publication_date":"2008-10-01","ids":{"openalex":"https://openalex.org/W2048657397","doi":"https://doi.org/10.1097/ftd.0b013e3181867a6e","mag":"2048657397","pmid":"https://pubmed.ncbi.nlm.nih.gov/18728627"},"language":"en","primary_location":{"id":"doi:10.1097/ftd.0b013e3181867a6e","doi":"https://doi.org/10.1097/ftd.0b013e3181867a6e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0b013e3181867a6e","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059262615","display_name":"Silvia Baroncelli","orcid":"https://orcid.org/0000-0002-2050-9037","observed_orcids":["https://orcid.org/0000-0002-2050-9037","https://orcid.org/0000-0002-9046-5877"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Silvia Baroncelli","raw_affiliation_strings":["Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, Rome, Italy","institution_ids":["https://openalex.org/I27897274"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paola Villani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paola Villani","raw_affiliation_strings":["Department of Pharmacology, Fondazione IRCCS Policlinico San Matteo, Pavia","IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fondazione IRCCS Policlinico San Matteo, Pavia","institution_ids":["https://openalex.org/I4210151645"]},{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017481279","display_name":"Marco Floridia","orcid":"https://orcid.org/0000-0003-3971-0141","observed_orcids":["https://orcid.org/0000-0003-3971-0141"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Marco Floridia","raw_affiliation_strings":["Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome","Istituto Superiore di Sanit\u00e0 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome","institution_ids":["https://openalex.org/I27897274"]},{"raw_affiliation_string":"Istituto Superiore di Sanit\u00e0 ,","institution_ids":["https://openalex.org/I27897274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047777094","display_name":"Maria Franca Pirillo","orcid":"https://orcid.org/0000-0002-6186-692X","observed_orcids":["https://orcid.org/0000-0002-6186-692X"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Maria F Pirillo","raw_affiliation_strings":["Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome","Istituto Superiore di Sanit\u00e0 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome","institution_ids":["https://openalex.org/I27897274"]},{"raw_affiliation_string":"Istituto Superiore di Sanit\u00e0 ,","institution_ids":["https://openalex.org/I27897274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075956703","display_name":"Clementina Maria Galluzzo","orcid":"https://orcid.org/0000-0003-1392-6569","observed_orcids":["https://orcid.org/0000-0003-1392-6569"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Clementina M Galluzzo","raw_affiliation_strings":["Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome","Istituto Superiore di Sanit\u00e0 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome","institution_ids":["https://openalex.org/I27897274"]},{"raw_affiliation_string":"Istituto Superiore di Sanit\u00e0 ,","institution_ids":["https://openalex.org/I27897274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111966660","display_name":"Maria P. Cusato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Cusato","raw_affiliation_strings":["Department of Pharmacology, Fondazione IRCCS Policlinico San Matteo, Pavia","IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fondazione IRCCS Policlinico San Matteo, Pavia","institution_ids":["https://openalex.org/I4210151645"]},{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049170322","display_name":"Roberta Amici","orcid":"https://orcid.org/0000-0002-0852-9203","observed_orcids":["https://orcid.org/0000-0002-0852-9203"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Roberta Amici","raw_affiliation_strings":["Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome","Istituto Superiore di Sanit\u00e0 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome","institution_ids":["https://openalex.org/I27897274"]},{"raw_affiliation_string":"Istituto Superiore di Sanit\u00e0 ,","institution_ids":["https://openalex.org/I27897274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003231872","display_name":"Carmela Pinnetti","orcid":"https://orcid.org/0000-0003-1350-4032","observed_orcids":["https://orcid.org/0000-0003-1350-4032"]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]},{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carmela Pinnetti","raw_affiliation_strings":["Department of Infectious Diseases, Catholic University, Rome","Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Catholic University, Rome","institution_ids":["https://openalex.org/I103320735"]},{"raw_affiliation_string":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","institution_ids":["https://openalex.org/I4210091493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108597269","display_name":"Francesca Sabbatini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122346577","display_name":"University of Modena and Reggio Emilia","ror":"https://ror.org/02d4c4y02","country_code":"IT","type":"education","lineage":["https://openalex.org/I122346577"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Sabbatini","raw_affiliation_strings":["Department of Medical Specialties, Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena","Univ of Modena and Reggio Emilia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Specialties, Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena","institution_ids":["https://openalex.org/I122346577"]},{"raw_affiliation_string":"Univ of Modena and Reggio Emilia","institution_ids":["https://openalex.org/I122346577"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027771306","display_name":"Atim Molinari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]},{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Atim Molinari","raw_affiliation_strings":["Department of Infectious Diseases and Hepatology, Azienda Ospedaliera di Parma, Parma, Italy","University Hospital of Parma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases and Hepatology, Azienda Ospedaliera di Parma, Parma, Italy","institution_ids":["https://openalex.org/I4210135416"]},{"raw_affiliation_string":"University Hospital of Parma","institution_ids":["https://openalex.org/I124601658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053575436","display_name":"Enrica Tamburrini","orcid":"https://orcid.org/0000-0003-4930-426X","observed_orcids":["https://orcid.org/0000-0003-4930-426X"]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Enrica Tamburrini","raw_affiliation_strings":["Department of Infectious Diseases, Catholic University, Rome","Universit\u00e0 Cattolica del Sacro Cuore, Rome#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Catholic University, Rome","institution_ids":["https://openalex.org/I103320735"]},{"raw_affiliation_string":"Universit\u00e0 Cattolica del Sacro Cuore, Rome#TAB#","institution_ids":["https://openalex.org/I103320735"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108501150","display_name":"Mario Bonora Regazzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mario Regazzi","raw_affiliation_strings":["Department of Pharmacology, Fondazione IRCCS Policlinico San Matteo, Pavia","IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fondazione IRCCS Policlinico San Matteo, Pavia","institution_ids":["https://openalex.org/I4210151645"]},{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5017481279","https://openalex.org/A5047777094","https://openalex.org/A5049170322","https://openalex.org/A5059262615","https://openalex.org/A5075956703"],"corresponding_institution_ids":["https://openalex.org/I27897274"],"apc_list":null,"apc_paid":null,"fwci":0.6659,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.72384926,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"30","issue":"5","first_page":"604","last_page":"610"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.02810000069439411,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-in-pregnancy","display_name":"HIV in pregnancy","score":0.875},{"id":"https://openalex.org/keywords/trough-concentration","display_name":"trough concentration","score":0.7279999852180481},{"id":"https://openalex.org/keywords/lopinavir-ritonavir","display_name":"lopinavir/ritonavir","score":0.9599999785423279},{"id":"https://openalex.org/keywords/nelfinavir","display_name":"nelfinavir","score":0.996999979019165},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":1.0},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9340000152587891},{"id":"https://openalex.org/keywords/subtherapeutic-drug-concentrations","display_name":"subtherapeutic drug concentrations","score":0.8450000286102295},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.6959999799728394},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.8840000033378601},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.625},{"id":"https://openalex.org/keywords/third-trimester","display_name":"third trimester","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C2781160516","wikidata":"https://www.wikidata.org/wiki/Q423366","display_name":"Nelfinavir","level":5,"score":0.9437434077262878},{"id":"https://openalex.org/C2777182164","wikidata":"https://www.wikidata.org/wiki/Q422585","display_name":"Lopinavir","level":5,"score":0.9338071346282959},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.8740406036376953},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.8090487122535706},{"id":"https://openalex.org/C2781392899","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Lopinavir/ritonavir","level":5,"score":0.7598987221717834},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.689184308052063},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5683552026748657},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.5559459328651428},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4952527582645416},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4575568437576294},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.4518439769744873},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.4400927722454071},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.4387887120246887},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42355093359947205},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.4235479235649109},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4123706817626953},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2481098175048828},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.13172847032546997}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011247","descriptor_name":"Pregnancy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011251","descriptor_name":"Pregnancy Complications, Infectious","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011251","descriptor_name":"Pregnancy Complications, Infectious","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011251","descriptor_name":"Pregnancy Complications, Infectious","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D019888","descriptor_name":"Nelfinavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019888","descriptor_name":"Nelfinavir","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D019888","descriptor_name":"Nelfinavir","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061466","descriptor_name":"Lopinavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/ftd.0b013e3181867a6e","doi":"https://doi.org/10.1097/ftd.0b013e3181867a6e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0b013e3181867a6e","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:18728627","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18728627","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322278","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1976555027","https://openalex.org/W1977123905","https://openalex.org/W1983133758","https://openalex.org/W1992150295","https://openalex.org/W1992916742","https://openalex.org/W1999487909","https://openalex.org/W2004929843","https://openalex.org/W2005206478","https://openalex.org/W2005771399","https://openalex.org/W2014053790","https://openalex.org/W2050303897","https://openalex.org/W2054173421","https://openalex.org/W2059341439","https://openalex.org/W2062388675","https://openalex.org/W2067065001","https://openalex.org/W2068428266","https://openalex.org/W2071521643","https://openalex.org/W2074576600","https://openalex.org/W2075068500","https://openalex.org/W2083192082","https://openalex.org/W2106737113","https://openalex.org/W2110293841","https://openalex.org/W2110650928","https://openalex.org/W2120660248","https://openalex.org/W2123052686","https://openalex.org/W2135892517","https://openalex.org/W2144905510","https://openalex.org/W2155050390","https://openalex.org/W2157902463","https://openalex.org/W2159601567","https://openalex.org/W2312930817","https://openalex.org/W2321838878","https://openalex.org/W2324423605","https://openalex.org/W2395631079","https://openalex.org/W2416791714"],"related_works":["https://openalex.org/W1551426618","https://openalex.org/W1980664033","https://openalex.org/W1992150295","https://openalex.org/W2336280597","https://openalex.org/W2164626605","https://openalex.org/W3031913460","https://openalex.org/W2021955917","https://openalex.org/W2080393808","https://openalex.org/W2028280602","https://openalex.org/W2134701335"],"abstract_inverted_index":{"The":[0,92],"objective":[1],"of":[2,30,32,54,125,161,171,188],"this":[3],"study":[4],"was":[5,184,220],"to":[6,26,97],"evaluate":[7],"the":[8,28,51,158,223],"plasma":[9,138],"drug":[10,100,117],"concentrations":[11,34,118,139,203],"in":[12,50,56,121,186],"human":[13],"immunodeficiency":[14],"virus":[15],"(HIV)-infected":[16],"pregnant":[17,206],"women":[18,46,126,176,189,207],"receiving":[19,127,155,177],"highly":[20],"active":[21],"antiretroviral":[22,39],"therapy":[23],"(HAART)":[24],"and":[25,109,130,149,173,179],"define":[27,98],"rate":[29],"occurrence":[31],"subtherapeutic":[33],"for":[35,143,147,152,194,199],"some":[36],"commonly":[37,210],"used":[38,96],"drugs":[40],"during":[41],"pregnancy.":[42],"We":[43],"evaluated":[44],"HIV-infected":[45,205],"(n":[47],"=":[48],"68)":[49],"third":[52],"trimester":[53],"pregnancy":[55],"steady-state":[57],"treatment":[58],"with":[59,169,190,212,215,222],"an":[60],"HAART":[61],"regimen":[62],"administrated":[63],"on":[64],"a":[65,67,122],"twice":[66],"day":[68],"basis,":[69],"which":[70],"included":[71],"2":[72],"nucleoside":[73],"reverse":[74],"transcriptase":[75],"inhibitors":[76],"plus":[77],"nelfinavir":[78],"(NFV),":[79],"lopinavir/ritonavir":[80,156],"(LPV/r),":[81],"or":[82],"nevirapine":[83],"(NVP).":[84],"Blood":[85],"samples":[86,196],"were":[87,95,119,140,197,208],"collected":[88],"at":[89],"predose":[90,114,202],"(C(trough)).":[91],"following":[93],"thresholds":[94],"therapeutic":[99],"concentrations-NFV:":[101],"0.8":[102],"microg/mL;":[103],"LPV:":[104],"4.0":[105],"microg/mL/1.0":[106],"microg/mL":[107,142,146,151],"(experienced/naive);":[108],"NVP:":[110],"3.1":[111,150],"microg/mL.":[112],"At":[113],"sampling,":[115],"adequate":[116],"found":[120,211],"higher":[123],"proportion":[124],"NFV":[128],"(70.8%)":[129],"LPV":[131,218],"(75.0%)":[132],"than":[133,214],"NVP":[134,178,213],"(55.6%).":[135],"Median":[136],"C(trough)":[137],"1.2":[141],"NFV,":[144,180],"5.5":[145],"LPV,":[148],"NVP.":[153],"Women":[154],"had":[157],"lowest":[159],"rates":[160,170],"detectable":[162,191],"(>50":[163],"copies/mL)":[164],"HIV":[165,192],"RNA":[166,193],"(15.4%)":[167],"compared":[168],"22.2%":[172],"41.7%":[174],"among":[175,204],"respectively.":[181],"Genotypic":[182],"resistance":[183],"detected":[185],"50%":[187],"whom":[195],"available":[198],"testing.":[200],"Subtherapeutic":[201],"more":[209],"protease":[216],"inhibitors.":[217],"administration":[219],"associated":[221],"best":[224],"viral":[225],"load":[226],"suppression.":[227]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}